Search research articles
Contact Us
Filters
Showing results (11-20 of 490) with videos related to
Page
of 49
Sort By:
Psychopharmacology
|
September 6, 2006
Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol
Lance R McMahon
Drug and Alcohol Dependence
|
June 13, 2016
Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
Lance R McMahon
Respiration Physiology
|
November 24, 2001
Respiratory and circulatory compensation to hypoxia in crustaceans
B R McMahon
Expert Review of Clinical Pharmacology
|
January 17, 2019
Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics
Lance R McMahon
Journal of Advanced Nursing
|
October 1, 1992
Skin problems beneath the breasts of in-patients: the knowledge, opinions and practice of nurses
R McMahon, J Buckeldee
Cureus
|
May 8, 2023
Transanal Minimally Invasive Surgery for Marsupialization of Chronic Abscess Cavity After Colorectal Anastomosis
Kevin R McMahon, Truong Ma
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2017
Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys
Lenka Hruba, Lance R McMahon
European Journal of Pharmacology
|
February 4, 2014
The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys
Lenka Hruba, Lance R McMahon
European Journal of Pharmacology
|
June 8, 2007
Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice
Lance R McMahon, Wouter Koek
Prostaglandins & Other Lipid Mediators
|
June 16, 2009
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability
Andrea Giuffrida, Lance R McMahon
Page
of 49
Search research articles
Search
Showing results (11-20 of 490) with videos related to
Sort By:
Page
of 49
Psychopharmacology
|
September 6, 2006
Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol
Lance R McMahon
Drug and Alcohol Dependence
|
June 13, 2016
Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
Lance R McMahon
Respiration Physiology
|
November 24, 2001
Respiratory and circulatory compensation to hypoxia in crustaceans
B R McMahon
Expert Review of Clinical Pharmacology
|
January 17, 2019
Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics
Lance R McMahon
Journal of Advanced Nursing
|
October 1, 1992
Skin problems beneath the breasts of in-patients: the knowledge, opinions and practice of nurses
R McMahon, J Buckeldee
Cureus
|
May 8, 2023
Transanal Minimally Invasive Surgery for Marsupialization of Chronic Abscess Cavity After Colorectal Anastomosis
Kevin R McMahon, Truong Ma
The Journal of Pharmacology and Experimental Therapeutics
|
May 24, 2017
Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys
Lenka Hruba, Lance R McMahon
European Journal of Pharmacology
|
February 4, 2014
The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys
Lenka Hruba, Lance R McMahon
European Journal of Pharmacology
|
June 8, 2007
Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice
Lance R McMahon, Wouter Koek
Prostaglandins & Other Lipid Mediators
|
June 16, 2009
In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability
Andrea Giuffrida, Lance R McMahon
Page
of 49